Cargando…
New Zealand’s Drug Development Industry
The pharmaceutical industry’s profitability depends on identifying and successfully developing new drug candidates while trying to contain the increasing costs of drug development. It is actively searching for new sources of innovative compounds and for mechanisms to reduce the enormous costs of dev...
Autores principales: | Lockhart, Michelle Marie, Babar, Zaheer-Ud-Din, Carswell, Christopher, Garg, Sanjay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799511/ https://www.ncbi.nlm.nih.gov/pubmed/24065037 http://dx.doi.org/10.3390/ijerph10094339 |
Ejemplares similares
-
Pharmaceutical policies in Australia and New Zealand
por: Babar, Zaheer-Ud-Din
Publicado: (2015) -
Identifying priority medicines policy issues for New Zealand: a general inductive study
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2014) -
New Zealand consumers’ perceptions of private insurance for pharmaceuticals
por: Ragupathy, Rajan, et al.
Publicado: (2014) -
A qualitative evaluation of general practitioners' perceptions regarding access to medicines in New Zealand
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2012) -
Prices of oncology medicines in European countries, Australia and New Zealand
por: Vogler, Sabine, et al.
Publicado: (2015)